Corbus Pharmaceuticals Inc.
Clinical trials sponsored by Corbus Pharmaceuticals Inc., explained in plain language.
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called CRB-701 for people with advanced solid tumors that have a specific protein (nectin-4). The goal is to find a safe and effective dose and see which cancers it may help. Participants receive the drug through an IV and are monitored with scans and …
Phase: PHASE1, PHASE2 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 10:25 UTC
-
New obesity drug CRB-913 enters human testing
Disease control Recruiting nowThis study tests an experimental drug called CRB-913 in people with obesity. The goal is to see if it is safe, how the body processes it, and whether it helps with weight loss. The study has two parts: one measures drug levels in healthy adults, and the other compares three doses…
Phase: PHASE1 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC